SAM
SRPT icon

Smartleaf Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Smartleaf Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.11K Hold
359
– – ﹤0.01% 2605
2026
Q1 		$7.35K Sell
359
-189
-34% -$3.66K ﹤0.01% 2464
2025
Q4 		$11.8K Buy
548
+479
+694% +$10.1K ﹤0.01% 2320
2025
Q3 		$1.3K Sell
69
-63
-48% -$1.12K ﹤0.01% 2699
2025
Q2 		$2.26K Sell
132
-179
-58% -$7.64K ﹤0.01% 2304
2025
Q1 		$21.9K Sell
311
-131
-30% -$13.8K ﹤0.01% 1566
2024
Q4 		$53.6K Buy
442
+216
+96% +$26.5K 0.01% 1151
2024
Q3 		$28.1K Buy
226
+114
+102% +$15.8K ﹤0.01% 1154
2024
Q2 		$17.7K Buy
112
+57
+104% +$7.32K ﹤0.01% 1089
2024
Q1 		$7.16K Hold
55
– – ﹤0.01% 1101
2023
Q4 		$5.38K Buy
+55
New +$5.28K ﹤0.01% 853

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Smartleaf Asset Management's SRPT Position: Q2 2026 in Review

Smartleaf Asset Management held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 359 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.

Smartleaf Asset Management first reported a position in SRPT in Q4 2023 and has held it in 11 quarters since. The position peaked at $53.6K in Q4 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Smartleaf Asset Management held 359 shares of Sarepta Therapeutics worth $6.11K as of Q2 2026.
  • Smartleaf Asset Management left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2605 holding.
  • Smartleaf Asset Management first reported a position in Sarepta Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Sarepta Therapeutics position peaked at $53.6K in Q4 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.